{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T23:45:50Z","timestamp":1791762350022,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13963-7","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:23:58Z","timestamp":1784042638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical implications in patients with isolation of Candidozyma auris in a single tertiary hospital"],"prefix":"10.1186","volume":"26","author":[{"given":"Taewoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0486-6608","authenticated-orcid":false,"given":"Yu-Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"9","key":"13963_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/1568026618666180528121707","volume":"18","author":"V Srivastava","year":"2018","unstructured":"Srivastava V, Singla RK, Dubey AK. Emerging virulence, drug resistance and future anti-fungal drugs for Candida pathogens. Curr Top Med Chem. 2018;18(9):759\u201378. https:\/\/doi.org\/10.2174\/1568026618666180528121707.","journal-title":"Curr Top Med Chem"},{"key":"13963_CR2","doi-asserted-by":"crossref","unstructured":"Wu PF, Liu WL, Hsieh MH, Hii IM, Lee YL, Lin YT, et al. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients. Emerg Microbes Infect. 2017;6(10):e87.","DOI":"10.1038\/emi.2017.74"},{"key":"13963_CR3","doi-asserted-by":"publisher","unstructured":"Berkow EL, Lockhart SR. Fluconazole resistance in candida species: a current perspective. Infect Drug Resist. 2017;10:237\u201345. https:\/\/doi.org\/10.2147\/IDR.S118892.","DOI":"10.2147\/IDR.S118892"},{"issue":"2","key":"13963_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3947\/ic.2022.0008","volume":"54","author":"A Sanyaolu","year":"2022","unstructured":"Sanyaolu A, Okorie C, Marinkovic A, Abbasi AF, Prakash S, Mangat J, et al. Candida auris: an overview of the emerging drug-resistant fungal infection. Infect Chemother. 2022;54(2):236. https:\/\/doi.org\/10.3947\/ic.2022.0008.","journal-title":"Infect Chemother"},{"issue":"1","key":"13963_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","volume":"53","author":"K Satoh","year":"2009","unstructured":"Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41\u201344. https:\/\/doi.org\/10.1111\/j.1348-0421.2008.00083.x.","journal-title":"Microbiol Immunol"},{"issue":"4","key":"13963_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/microorganisms9040807","volume":"9","author":"S Ahmad","year":"2021","unstructured":"Ahmad S, Alfouzan W. Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms. 2021;9(4):807. https:\/\/doi.org\/10.3390\/microorganisms9040807.","journal-title":"Microorganisms"},{"key":"13963_CR7","doi-asserted-by":"publisher","unstructured":"Casadevall A, Kontoyiannis DP, Robert V. On the emergence of Candida auris: climate change, azoles, swamps, and birds. mBio. 2019;10(4). https:\/\/doi.org\/10.1128\/mBio.01397-19.","DOI":"10.1128\/mBio.01397-19"},{"issue":"5","key":"13963_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/microorganisms12050927","volume":"12","author":"S De Gaetano","year":"2024","unstructured":"De Gaetano S, Midiri A, Mancuso G, Avola MG, Biondo C. Candida auris outbreaks: current status and future perspectives. Microorganisms. 2024;12(5):927. https:\/\/doi.org\/10.3390\/microorganisms12050927.","journal-title":"Microorganisms"},{"issue":"10","key":"13963_CR9","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/JCM.00921-17","volume":"55","author":"RM Welsh","year":"2017","unstructured":"Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55(10):2996\u20133005.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"13963_CR10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/myc.12699","volume":"60","author":"A Abdolrasouli","year":"2017","unstructured":"Abdolrasouli A, Armstrong-James D, Ryan L, Schelenz S. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris. Mycoses. 2017;60(11):758\u201363. https:\/\/doi.org\/10.1111\/myc.12699.","journal-title":"Mycoses"},{"key":"13963_CR11","doi-asserted-by":"publisher","first-page":"658329","DOI":"10.3389\/fmicb.2021.658329","volume":"12","author":"S Hu","year":"2021","unstructured":"Hu S, Zhu F, Jiang W, Wang Y, Quan Y, Zhang G, et al. Retrospective analysis of the clinical characteristics of Candida auris infection worldwide from 2009 to 2020. Front Microbiol. 2021;12:658329. https:\/\/doi.org\/10.3389\/fmicb.2021.658329.","journal-title":"Front Microbiol"},{"key":"13963_CR12","unstructured":"Organization WH. Global antimicrobial resistance and use surveillance system (GLASS) report. Geneva, Switzerland: World Health Organization; 2020."},{"key":"13963_CR13","volume-title":"WHO fungal priority pathogens list to guide research, development and public health action","author":"WH Organization","year":"2022","unstructured":"Organization WH. WHO fungal priority pathogens list to guide research, development and public health action. Geneva, Switzerland: World Health Organization; 2022."},{"key":"13963_CR14","unstructured":"Infection Control Guidance: Candida auris. https:\/\/www.cdc.gov\/candida-auris\/hcp\/infection-control\/."},{"key":"13963_CR15","unstructured":"Candidozyma auris: guidance for acute healthcare settings. https:\/\/www.gov.uk\/government\/publications\/candida-auris-laboratory-investigation-management-and-infection-prevention-and-control?utm_source=chatgpt.com."},{"key":"13963_CR16","unstructured":"Candida auris in healthcare settings - Europe. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/RRA-Candida-auris-European-Union-countries.pdf."},{"issue":"1","key":"13963_CR17","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1080\/22221751.2022.2125349","volume":"11","author":"B Spruijtenburg","year":"2022","unstructured":"Spruijtenburg B, Badali H, Abastabar M, Mirhendi H, Khodavaisy S, Sharifisooraki J, et al. Confirmation of fifth Candida auris clade by whole genome sequencing. Emerg Microbes Infect. 2022;11(1):2405\u201311. https:\/\/doi.org\/10.1080\/22221751.2022.2125349.","journal-title":"Emerging Microbes Infections"},{"key":"13963_CR18","doi-asserted-by":"publisher","unstructured":"Khan T, Faysal NI, Hossain MM, Mah-E-Muneer S, Haider A, Moon SB, et al. Emergence of the novel sixth Candida auris Clade VI in Bangladesh. Microbiol Spectr. 2024;12(7):e03540\u201303523. https:\/\/doi.org\/10.1128\/spectrum.03540-23.","DOI":"10.1128\/spectrum.03540-23"},{"issue":"7","key":"13963_CR19","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cmi.2025.04.003","volume":"31","author":"KJG da Silva","year":"2025","unstructured":"da Silva KJG, Lucini F, Dos Santos RAC, Santos DA, Meis JF, Melhem MSC, et al. How does antifungal resistance vary in Candida (Candidozyma) auris and its clades? Quantitative and qualitative analyses and their clinical implications. Clin Microbiol Infect. 2025;31(7):1146\u201356. https:\/\/doi.org\/10.1016\/j.cmi.2025.04.003.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"13963_CR20","first-page":"323","volume":"31","author":"F Pallotta","year":"2023","unstructured":"Pallotta F, Viale P, Barchiesi F. Candida auris: the new fungal threat. Infez Med. 2023;31(3):323\u201328.","journal-title":"Le infezioni medicina"},{"key":"13963_CR21","doi-asserted-by":"publisher","first-page":"102208","DOI":"10.1016\/j.mib.2022.102208","volume":"70","author":"JM Rybak","year":"2022","unstructured":"Rybak JM, Cuomo CA, Rogers PD. The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris. Curr Opin Microbiol. 2022;70:102208. https:\/\/doi.org\/10.1016\/j.mib.2022.102208.","journal-title":"Curr Opin Microbiol"},{"issue":"10","key":"13963_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/jof9100979","volume":"9","author":"SA Byun","year":"2023","unstructured":"Byun SA, Kwon YJ, Lee GY, Choi MJ, Jeong SH, Kim D, et al. Virulence traits and azole resistance in Korean Candida auris isolates. J Fungi (Basel). 2023;9(10):979. https:\/\/doi.org\/10.3390\/jof9100979.","journal-title":"J Fungi (Basel)"},{"key":"13963_CR23","doi-asserted-by":"publisher","unstructured":"Kwon YJ, Shin JH, Byun SA, Choi MJ, Won EJ, Lee D, et al. Candida auris clinical isolates from South Korea: identification, antifungal susceptibility, and genotyping. J Clin Microbiol. 2019;57(4). https:\/\/doi.org\/10.1128\/JCM.01624-18.","DOI":"10.1128\/JCM.01624-18"},{"issue":"1","key":"13963_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.14192\/kjicp.2022.27.1.4","volume":"27","author":"YJ Kwon","year":"2022","unstructured":"Kwon YJ, Shin JH. Detection and control of Candida auris in healthcare settings. Korean J Healthcare-Associated Infect Control Prev. 2022;27(1):4\u201317. https:\/\/doi.org\/10.14192\/kjicp.2022.27.1.4.","journal-title":"Korean J Healthcare-Associated Infect Control Prev"},{"issue":"5","key":"13963_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"issue":"3","key":"13963_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","volume":"34","author":"C Le\u00f3n","year":"2006","unstructured":"Le\u00f3n C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, et al. A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34(3):730\u201337. https:\/\/doi.org\/10.1097\/01.CCM.0000202208.37364.7D.","journal-title":"Crit Care Med"},{"issue":"8","key":"13963_CR27","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):775\u201387. https:\/\/doi.org\/10.1001\/jama.2016.0289.","journal-title":"JAMA"},{"key":"13963_CR28","doi-asserted-by":"publisher","unstructured":"Kwon YJ, Shin JH, Byun SA, Choi MJ, Won EJ, Lee D, et al. Candida auris clinical isolates from South Korea: identification, antifungal susceptibility, and genotyping. 2019;57(4). https:\/\/doi.org\/10.1128\/JCM.01624-18.","DOI":"10.1128\/JCM.01624-18"},{"key":"13963_CR29","volume-title":"auris","author":"C Tracking","year":"2024","unstructured":"Tracking C. auris. US Centers for Disease Control and Prevention; 2024."},{"issue":"1","key":"13963_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.47429\/lmo.2022.12.1.40","volume":"12","author":"T Ma","year":"2022","unstructured":"Ma T, In YH, Byun SA, Lee GY, Choi MJ, Lee SY, et al. Identification of Candida auris and closely related species using a new matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry, the ASTA MicroIDSys system. Lab Med Online. 2022;12(1):40\u201345. https:\/\/doi.org\/10.47429\/lmo.2022.12.1.40.","journal-title":"Lab Med Online"},{"key":"13963_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jhin.2023.10.017","volume":"143","author":"E Lee","year":"2024","unstructured":"Lee E, Choi M, Lee K, Kim D, Jeong S, Song Y, et al. Intrahospital transmission and infection control of Candida auris originating from a severely infected COVID-19 patient transferred abroad. J Hosp Infect. 2024;143:140\u201349. https:\/\/doi.org\/10.1016\/j.jhin.2023.10.017.","journal-title":"J Hosp Infect"},{"key":"13963_CR32","unstructured":"Guidelines for infection prevention and control of Candida auris in healthcare settings. https:\/\/www.kdca.go.kr\/kdca\/2861\/subview.do."},{"key":"13963_CR33","doi-asserted-by":"publisher","unstructured":"Al Jabi S, El-Lababidi R, Abidi E, Afif C, El Nekidy WS. Clinical outcomes amongst patients infected with Candida auris: a single-center study. Mycoses. 2025;68(4):e70054. https:\/\/doi.org\/10.1111\/myc.70054.","DOI":"10.1111\/myc.70054"},{"issue":"1","key":"13963_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12879-019-3999-y","volume":"19","author":"MA Sayeed","year":"2019","unstructured":"Sayeed MA, Farooqi J, Jabeen K, Awan S, Mahmood SF. Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan. BMC Infect Dis. 2019;19(1):384. https:\/\/doi.org\/10.1186\/s12879-019-3999-y.","journal-title":"BMC Infect Dis"},{"key":"13963_CR35","doi-asserted-by":"publisher","unstructured":"G\u00fclten E, \u00c7\u0131nar G, Sar\u0131cao\u011flu EM, Akdemir \u0130, Y\u0131lmaz AZ, Saldere EH, et al. Candida auris vs. Non-Candida auris candidemia in critically ill patients: clinical outcomes, risk factors, and mortality. J Fungi (Basel). 2025;11(8). https:\/\/doi.org\/10.3390\/jof11080552.","DOI":"10.3390\/jof11080552"},{"key":"13963_CR36","doi-asserted-by":"publisher","unstructured":"Simon SP, Li R, Silver M, Andrade J, Tharian B, Fu L, et al. Comparative outcomes of Candida auris bloodstream infections: a multicenter retrospective case-control study. Clin Infect Dis. 2023;76(3):e1436\u201343. https:\/\/doi.org\/10.1093\/cid\/ciac735.","DOI":"10.1093\/cid\/ciac735"},{"issue":"5","key":"13963_CR37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3201\/eid2605.191588","volume":"26","author":"K Arensman","year":"2020","unstructured":"Arensman K, Miller JL, Chiang A, Mai N, Levato J, LaChance E, et al. Clinical outcomes of patients treated for Candida auris infections in a multisite health system, Illinois, USA. Emerg Infect Dis. 2020;26(5):876\u201380. https:\/\/doi.org\/10.3201\/eid2605.191588.","journal-title":"Emerg Infect Dis"},{"key":"13963_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhin.2025.03.014","volume":"161","author":"E Paramythiotou","year":"2025","unstructured":"Paramythiotou E, Kyriazopoulou E, Karakike E, Siopi M, Frantzeskaki F, Meletiadis J, et al. Clinical characteristics and outcome of Candida auris bloodstream infections during an outbreak in a Greek tertiary academic intensive care unit. J Hosp Infect. 2025;161:25\u201327. https:\/\/doi.org\/10.1016\/j.jhin.2025.03.014.","journal-title":"J Hosp Infect"},{"issue":"8","key":"13963_CR39","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3201\/eid3108.250315","volume":"31","author":"AD Baker","year":"2025","unstructured":"Baker AD, Gold JAW, Forsberg K, Jones S, Lyman MM. Progression from Candida auris colonization screening to clinical case status, United States, 2016\u20132023. Emerg Infect Dis. 2025;31(8):1613\u201317. https:\/\/doi.org\/10.3201\/eid3108.250315.","journal-title":"Emerg Infect Dis"},{"key":"13963_CR40","doi-asserted-by":"publisher","unstructured":"Pacilli M, Kerins JL, Clegg WJ, Walblay KA, Adil H, Kemble SK, et al. Regional Emergence of Candida auris in Chicago and lessons learned from intensive follow-up at 1 ventilator-capable skilled nursing facility. Clin Infect Dis. 2020;71(11):e718\u201325. https:\/\/doi.org\/10.1093\/cid\/ciaa435.","DOI":"10.1093\/cid\/ciaa435"},{"key":"13963_CR41","doi-asserted-by":"publisher","unstructured":"Jacobs SE, Jacobs JL, Dennis EK, Taimur S, Rana M, Patel D, et al. Candida auris pan-drug-resistant to four classes of antifungal agents. Antimicrob Agents Chemother. 2022;66(7):e0005322. https:\/\/doi.org\/10.1128\/aac.00053-22.","DOI":"10.1128\/aac.00053-22"},{"issue":"9","key":"13963_CR42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/antibiotics9090568","volume":"9","author":"MG Fr\u00edas-De-Le\u00f3n","year":"2020","unstructured":"Fr\u00edas-De-Le\u00f3n MG, Hern\u00e1ndez-Castro R, Vite-Gar\u00edn T, Arenas R, Bonifaz A, Casta\u00f1\u00f3n-Olivares L, et al. Antifungal resistance in Candida auris: molecular determinants. Antibiotics (Basel). 2020;9(9):568. https:\/\/doi.org\/10.3390\/antibiotics9090568.","journal-title":"Antibiot (Basel)"},{"key":"13963_CR43","doi-asserted-by":"crossref","unstructured":"Kang N, Hsu V-C, Bailey CC Jr. Successful treatment of Candida auris ventriculitis with intravenous liposomal amphotericin B and oral flucytosine: a case report. Open Forum Infect Dis. 2024;12(1).","DOI":"10.1093\/ofid\/ofae743"},{"key":"13963_CR44","doi-asserted-by":"publisher","unstructured":"Pfaller MA, Messer SA, Rhomberg PR, Borroto-Esoda K, Castanheira M. Differential Activity of the oral glucan synthase inhibitor SCY-078 against wild-type and echinocandin-resistant strains of Candida species. Antimicrob Agents Chemother. 2017;61(8). https:\/\/doi.org\/10.1128\/AAC.00161-17.","DOI":"10.1128\/AAC.00161-17"},{"issue":"7","key":"13963_CR45","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/14656566.2021.1890026","volume":"22","author":"RE Colombo","year":"2021","unstructured":"Colombo RE, Vazquez JA. An evaluation of ibrexafungerp for the treatment of invasive candidiasis: the evidence to date. Expert Opin Pharmacother. 2021;22(7):797\u2013807. https:\/\/doi.org\/10.1080\/14656566.2021.1890026.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"13963_CR46","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/jac\/dkaf124","volume":"80","author":"JB Locke","year":"2025","unstructured":"Locke JB, Andes D, Flanagan S, Redell M, Ong V, Aram JA, et al. Activity of rezafungin against Candida auris. J Antimicrob Chemother. 2025;80(6):1482\u201393. https:\/\/doi.org\/10.1093\/jac\/dkaf124.","journal-title":"The J Antimicrob Chemother"},{"issue":"4","key":"13963_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/jof6040239","volume":"6","author":"KJ Shaw","year":"2020","unstructured":"Shaw KJ, Ibrahim AS. Fosmanogepix: a Review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections. J Fungi (Basel). 2020;6(4):239. https:\/\/doi.org\/10.3390\/jof6040239.","journal-title":"J Fungi (Basel)"},{"key":"13963_CR48","doi-asserted-by":"publisher","unstructured":"Hernando-Ortiz A, Eraso E, Jauregizar N, de Groot PWJ, Quind\u00f3s G, Mateo E. Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model. Microbiol Spectr. 2024;12(1):e0208623. https:\/\/doi.org\/10.1128\/spectrum.02086-23.","DOI":"10.1128\/spectrum.02086-23"},{"key":"13963_CR49","doi-asserted-by":"publisher","first-page":"1241539","DOI":"10.3389\/ffunb.2023.1241539","volume":"4","author":"R Kumar","year":"2023","unstructured":"Kumar R, Srivastava V. Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance. Front Fungal Biol. 2023;4:1241539. https:\/\/doi.org\/10.3389\/ffunb.2023.1241539.","journal-title":"Front Fungal Biol"},{"key":"13963_CR50","doi-asserted-by":"publisher","unstructured":"Singh S, Uppuluri P, Mamouei Z, Alqarihi A, Elhassan H, French S, et al. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. PLoS Pathog. 2019;15(8):e1007460. https:\/\/doi.org\/10.1371\/journal.ppat.1007460.","DOI":"10.1371\/journal.ppat.1007460"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13963-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T23:39:52Z","timestamp":1791761992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13963-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13963"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13963-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Kyung Hee University Hospital (protocol code KHUH-2025-06-030, date of approval: 19 June 2025). Informed consent was waived by the Institutional Review Board of Kyung Hee University Hospital (protocol code KHUH-2025-6-030) owing to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1787"}}